CMS Open Payments · Program Year 2024
BioHorizons Implant Systems Inc.
BioHorizons Implant Systems Inc. reported $1,395,668.45 across General Payments, Research, and Ownership to 9,712 physicians and teaching hospitals across 9,712 transactions.
- $1.4M
- All-tracks total
- 9,712
- Transactions
- 9,712
- Recipients
- −$354.9K
- General Payments vs PY2023
BioHorizons Implant Systems Inc. reported $1,395,668.45 across all CMS Open Payments tracks (General + Research + Ownership) to 9,712 physicians and teaching hospitals in Program Year 2024 - ranking #538 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,395,668.45, averaging $143.71 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer biohorizons-implant-systems-inc BioHorizons Implant Systems Inc.
$1.4M · #538/1,925 · 0.0% industry · PY2024
- TOT $1.4M
- RANK #538
- SHARE 0.0%
- TXN 9,712
- RCP 9,712
- CAT 6
- GEN $1.4M
- ΔGEN −$354.9K
- TOP1 25.1%
- PY 2024
Volume peers
Nearest volume peer: Optinose US, Inc. ($1.4M)
BioHorizons Implant Systems Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
BioHorizons Implant Systems Inc.'s CMS-reported General Payments decreased by $354.9K (−20.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BIOHORIZONS IMPLANT SYSTEMS INC.PY2023: BIOHORIZONS IMPLANT SYSTEMS INC.PY2024: BioHorizons Implant Systems Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,750,543.52
- PY2024
- $1,395,668.45
What the Data Shows for BioHorizons Implant Systems Inc.
$1,395,668.45: that is what BioHorizons Implant Systems Inc. reported in payments to 9,712 physicians and teaching hospitals during Program Year 2024, spread across 9,712 transactions ($143.71 per transaction, $143.71 per recipient). The company sits at rank #538 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Compensation for Faculty or Speaker (Medical Education)" leads the 6-category general-payment breakdown below at $805.1K (57.7% of General Payments, 117 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 6 types of general payments, BioHorizons Implant Systems Inc.'s largest category was "Compensation for Faculty or Speaker (Medical Education)" at $805.1K - 57.7% of General Payments.
BioHorizons Implant Systems Inc. reports 6 general-payment categories - the top three are Compensation for Faculty or Speaker (Medical Education) (57.7%), Food and Beverage (22.4%), and Travel and Lodging (9.0%). The remaining 3 categories make up 10.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How BioHorizons Implant Systems Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Faculty or Speaker (Medical Education) | $805.1K | 117 | 57.7% |
| Food and Beverage | $312.7K | 9,352 | 22.4% |
| Travel and Lodging | $125.7K | 183 | 9.0% |
| Royalty or License | $76.0K | 4 | 5.4% |
| Compensation for Services Other Than Consulting | $55.0K | 34 | 3.9% |
| Consulting Fee | $21.2K | 22 | 1.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $653,065.27 (46.8%) of $1,395,668.45 in this company's General Payments records across 4,563 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for BioHorizons Implant Systems Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Michael Pikos
$350,231.79 across 49 reported transactions
- 2
Edward Allen
$101,799.89 across 18 reported transactions
- 3
Carl Medgaus
$77,992.25 across 12 reported transactions
- 4
Rick Ferguson
$66,744.34 across 14 reported transactions
- 5
Robert Stanley
$56,297.00 across 19 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as BioHorizons Implant Systems Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about BioHorizons Implant Systems Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with BioHorizons Implant Systems Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Djo, LLC
Tactile Systems Technology Inc
Aurora Spine, Inc.
Agile Devices, Inc.
Endovascular Engineering Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.